Hosted on MSN33m
FDA grants orphan drug status to Arbor Biotechnologies’ PH1
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) and rare paediatric disease designation (RPDD) to Arbor Biotechnologies' gene editing therapeutic, ABO-101, to treat ...
JD Supra55m
BIS Increases Export Controls on Key Biotech Equipment
BIS issued an Interim Final Rule that amends the Export Administration Regulation (EAR) to address dual use export ...